Tuesday 5th July 2016

Heart Valve Voice's CEO to join with health care professionals from around the UK to discuss the TAVI Trial

Wil Woan, CEO of Heart Valve Voice, will be attending a meeting for the UK TAVI Trial on the 5th July, following Heart Valve Voice's afternoon in Parliament.

The UK TAVI Trial is a multi-centre, randomised, controlled trial to assess the clinical effectiveness and cost-utility of UK TAVI, compared with conventional surgical aortic valve replacement. It involves patients with severe symptomatic aortic stenosis, who are at intermediate or high operative risk.

The meeting will bring together staff from across the UK to discuss the progress of the trial and its future developments. Heart Valve Voice are very pleased to have been invited to speak at the meeting in relation to patient engagement.